|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.145 EUR | +2.69% |
|
+4.57% | -22.11% |
| 06-15 | Laboratorio Farmaceutico Erfo acquires 15,000 treasury shares | AN |
| 06-04 | Equities trend higher; banks lead gains on the MIB | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 55 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 55 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.69% | +4.57% | -6.15% | -6.15% | 11.02M | ||
| -0.94% | -2.85% | +37.70% | +148.38% | 1,001B | ||
| -0.42% | -1.18% | +50.88% | +42.60% | 566B | ||
| -0.56% | -1.86% | +15.91% | +59.57% | 393B | ||
| -1.18% | +2.29% | +24.04% | +16.53% | 326B | ||
| +1.09% | +2.21% | +25.56% | +33.32% | 276B | ||
| +1.42% | -1.17% | +24.53% | +14.29% | 277B | ||
| +1.87% | +5.96% | -42.67% | -48.26% | 193B | ||
| -1.78% | -0.84% | +15.60% | +48.77% | 188B | ||
| -1.40% | -0.04% | +13.19% | +59.08% | 158B | ||
| Average | +0.54% | +0.50% | +15.86% | +36.81% | 337.68B | |
| Weighted average by Cap. | +0.22% | -0.41% | +27.02% | +66.27% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















